Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening Epidemiological Program on Compensation Evaluation of DM Type 2 Patients on OAD Monotherapy and Physicians Satisfaction of Their Usage

NCT01275794 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01275794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01275794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening Epidemiological Program on Compensation Evaluation of DM Type 2 Patients on OAD Monotherapy and Physicians Satisfaction of Their Usage
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
December 31, 2010
Completion date
March 31, 2011
Enrollment
1,849 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes